The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / C••••• L••••••• D••••••

R••••••••• C•••••• Announces New Partnership With C••••• L••••••• D•••••• (CLD)

Type not statedannouncedannounced Jul 31, 2025Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
education / learning, training
Target location
unknown
Seller kind
Founder
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
2 named
Buy side
  • Belmont, MA (July 31, 2025) – R••••••••• C•••••• (“RiverGlade”), a healthcare-focused private equity firm, has formed a new partnership with C••••• L••••••• D•••••• (“CLD” or the “Company”), a provider of technology enabled outsourced sales training solutions for pharmaceutical, biotech, and medical
Side not stated
Evidence
R••••••••• C•••••• Announces New Partnership With C••••• L••••••• D•••••• (CLD)
R••••••••• C•••••• Announces New Partnership With C••••• L••••••• D•••••• (CLD) | Private Equity Intelligence | DFX